BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 12518185)

  • 1. Angiotensin receptors in the cardiovascular system.
    Wagenaar LJ; Voors AA; Buikema H; van Gilst WH
    Can J Cardiol; 2002 Dec; 18(12):1331-9. PubMed ID: 12518185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of the selective blocking of angiotensin II receptors in the treatment of cardiovascular diseases].
    Carnovali M
    Clin Ter; 2001; 152(2):103-6. PubMed ID: 11441521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Renin-angiotensin system and heart failure].
    Suzuki J; Horiuchi M
    Nihon Rinsho; 2003 May; 61(5):751-5. PubMed ID: 12754998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiologic and pharmacologic implications of AT1 versus AT2 receptors.
    Chung O; Stoll M; Unger T
    Blood Press Suppl; 1996; 2():47-52. PubMed ID: 8913540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of angiotensin II receptors and their antagonists in hypertension.
    van Zwieten PA
    Ann Ital Med Int; 2000; 15(1):85-91. PubMed ID: 10842896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent progress in AT1 and AT2 receptor research].
    Horiuchi M
    Nihon Rinsho; 2002 Oct; 60(10):1873-80. PubMed ID: 12397677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II AT2 subtype receptors: an emerging target for cardiovascular therapy.
    Volpe M; De Paolis P
    Ital Heart J; 2000 Feb; 1(2):96-103. PubMed ID: 10730608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the angiotensin AT1 receptor expression by hypercholesterolemia.
    Nickenig G; Böhm M
    Eur J Med Res; 1997 Jul; 2(7):285-9. PubMed ID: 9233901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of angiotensin receptors in cardiovascular diseases.
    Helin K; Stoll M; Meffert S; Stroth U; Unger T
    Ann Med; 1997 Feb; 29(1):23-9. PubMed ID: 9073321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin receptors.
    Unger T; Chung O; Csikos T; Culman J; Gallinat S; Gohlke P; Höhle S; Meffert S; Stoll M; Stroth U; Zhu YZ
    J Hypertens Suppl; 1996 Dec; 14(5):S95-103. PubMed ID: 9120691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II--receptor subtypes characterization and pathophysiological implications.
    Gulati K; Lall SB
    Indian J Exp Biol; 1996 Feb; 34(2):91-7. PubMed ID: 8641721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to explain the differences between renin angiotensin system modulators.
    Levy BI
    Am J Hypertens; 2005 Sep; 18(9 Pt 2):134S-141S. PubMed ID: 16125050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin AT2 receptors: control of renal sodium excretion and blood pressure.
    Carey RM; Padia SH
    Trends Endocrinol Metab; 2008 Apr; 19(3):84-7. PubMed ID: 18294862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular biology and signaling of angiotensin receptors: an overview.
    Inagami T
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S2-7. PubMed ID: 9892133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The angiotensin II type 2 receptor in cardiovascular disease.
    Lemarié CA; Schiffrin EL
    J Renin Angiotensin Aldosterone Syst; 2010 Mar; 11(1):19-31. PubMed ID: 19861349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Working outside the system: an update on the unconventional behavior of the renin-angiotensin system components.
    Kurdi M; De Mello WC; Booz GW
    Int J Biochem Cell Biol; 2005 Jul; 37(7):1357-67. PubMed ID: 15833268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of angiotensin II type 1 and type 2 receptor on apoptosis].
    Ono H; Ishimitsu T
    Nihon Rinsho; 2002 Oct; 60(10):1887-92. PubMed ID: 12397679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Renin-angiotensin system and its role in cardiovascular physiopathology and therapy].
    Castro-Chaves P; Leite-Moreira AF
    Rev Port Cardiol; 2004 May; 23 Suppl 2():II61-77. PubMed ID: 15222251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice.
    Hein L; Barsh GS; Pratt RE; Dzau VJ; Kobilka BK
    Nature; 1995 Oct; 377(6551):744-7. PubMed ID: 7477266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
    Horký K
    Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.